These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37289208)

  • 1. Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy.
    Chen R; Dai J
    J Mol Med (Berl); 2023 Aug; 101(8):905-915. PubMed ID: 37289208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid metabolism in idiopathic pulmonary fibrosis].
    Fan LC; Chen Y; Luo QX; Xu JF
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):493-497. PubMed ID: 35527464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF).
    Nambiar S; Clynick B; How BS; King A; Walters EH; Goh NS; Corte TJ; Trengove R; Tan D; Moodley Y
    Respir Res; 2021 Apr; 22(1):105. PubMed ID: 33836757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CT
    O'Callaghan M; Duignan J; Tarling EJ; Waters DK; McStay M; O'Carroll O; Bridges JP; Redente EF; Franciosi AN; McGrath EE; Butler MW; Dodd JD; Fabre A; Murphy DJ; Keane MP; McCarthy C
    Respirology; 2023 Nov; 28(11):1043-1052. PubMed ID: 37642207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways.
    Suryadevara V; Ramchandran R; Kamp DW; Natarajan V
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: A review.
    Tian Y; Duan C; Feng J; Liao J; Yang Y; Sun W
    Int J Biochem Cell Biol; 2023 Feb; 155():106361. PubMed ID: 36592687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
    Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.
    Bargagli E; Refini RM; d'Alessandro M; Bergantini L; Cameli P; Vantaggiato L; Bini L; Landi C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis.
    Mohanan A; Washimkar KR; Mugale MN
    Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119676. PubMed ID: 38242330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in idiopathic pulmonary fibrosis: the pathogenesis, therapeutic strategies and candidate molecules.
    Lv M; Liu Y; Ma S; Yu Z
    Future Med Chem; 2019 Oct; 11(19):2595-2620. PubMed ID: 31633402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.
    Tanjore H; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(8):L721-9. PubMed ID: 22287606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis.
    Kou L; Kou P; Luo G; Wei S
    Oxid Med Cell Longev; 2022; 2022():6197219. PubMed ID: 35345828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance.
    Spagnolo P; Tonelli R; Samarelli AV; Castelli G; Cocconcelli E; Petrarulo S; Cerri S; Bernardinello N; Clini E; Saetta M; Balestro E
    Expert Opin Ther Targets; 2022 Jul; 26(7):617-631. PubMed ID: 35983984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
    Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
    Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung.
    Yan P; Liu J; Li Z; Wang J; Zhu Z; Wang L; Yu G
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids.
    Roque W; Romero F
    Am J Physiol Cell Physiol; 2021 May; 320(5):C689-C695. PubMed ID: 33471621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis.
    Deng J; Liu J; Chen W; Liang Q; He Y; Sun G
    Drug Des Devel Ther; 2024; 18():1627-1650. PubMed ID: 38774483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis.
    Zhu W; Tan C; Zhang J
    Lung; 2022 Oct; 200(5):539-547. PubMed ID: 36136136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.
    Phan THG; Paliogiannis P; Nasrallah GK; Giordo R; Eid AH; Fois AG; Zinellu A; Mangoni AA; Pintus G
    Cell Mol Life Sci; 2021 Mar; 78(5):2031-2057. PubMed ID: 33201251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.